Mon panier

Human IL-22 R alpha 1 Superstable Mutant Protein, His Tag (MALS & SPR verified)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
IL1-H52H7-100ug
$390.00
IL1-H52H7-1mg (500ug X 2)
$2575.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Synonyms

    Interleukin-22 receptor subunit alpha-1, IL-22 receptor subunit alpha-1, IL-22R-alpha-1, IL-22RA1, Cytokine receptor class-II member 9, Cytokine receptor family 2 member 9, CRF2-9, ZcytoR11, IL22RA1 , IL22R

  • Source

    Human IL-22 R alpha 1 Superstable Mutant Protein, His Tag (IL1-H52H7) is expressed from human 293 cells (HEK293). It contains AA Pro 18 - Thr 228 (Accession # Q8N6P7-1).

    Request for sequence
  • Molecular Characterization

    IL-22 R alpha 1 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 26.1 kDa. The protein migrates as 32-42 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • SDS-PAGE

    IL-22 R alpha 1 SDS-PAGE

    Human IL-22 R alpha 1 Superstable Mutant Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    IL-22 R alpha 1 SEC-MALS

    The purity of Human IL-22 R alpha 1 Superstable Mutant Protein, His Tag (Cat. No. IL1-H52H7) is more than 95% and the molecular weight of this protein is around 26-40 kDa verified by SEC-MALS.

    Report
  • Bioactivity-SPR

     IL-22 R alpha 1 SPR

    Human IL-22 R alpha 1 Superstable Mutant Protein, His Tag (Cat. No. IL1-H52H7) immobilized on CM5 Chip can bind Human IL-22, His Tag (Cat. No. IL2-H524a) with an affinity constant of 13.7 nM as determined in a SPR assay (Biacore 8K) (QC tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

Introduction de fond

Interleukin-22 receptor subunit alpha-1(IL22RA1) is a component of the receptor for IL20, IL22 and IL24.Component of IL22 receptor formed by IL22RA1 and IL10RB enabling IL22 signaling via JAK/STAT pathways. IL22 also induces activation of MAPK1/MAPK3 and Akt kinases pathways. Component of one of the receptor for IL20 and IL24 formed by IL22RA1 and IL20RB also signaling through STATs activation. Mediates IL24 antiangiogenic activity as well as IL24 inhibitory effect on endothelial cell tube formation and differentiation.

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Interleukin-22 receptor

  • Catégorie:

  • Nombre de médicaments répertoriés:

    0 Détails

  • Nombre de médicaments cliniques:

    5 Détails

  • Étape de développement la plus élevée:

    Phase 2 Clinical

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Contexte